Abstract
Any important aggression toward our bodies leads to a complex systemic inflammatory response that can be expressed by biomarkers. Thus biomarkers can help us to diagnose and manage the initial aggression. Application of biomarkers to ventilator-associated pneumonia (VAP) has two additional difficulties: the lack of universal consensus regarding the diagnostic criteria and the difficulty of discriminating the inflammatory response secondary to VAP in a context (that of ventilated critical-care patients) in which there is already a nonspecific inflammatory response. However, biomarkers have been studied in VAP and promising results have been achieved concerning diagnosis and follow-up. The most studied biomarkers have been C-reactive protein, procalcitonin, sTREM-1 and cytokines. Nevertheless, heterogeneicity of results makes difficult to apply conclusions to the general ICU population. Authors differ in VAP diagnosis criteria and in the selection of the control group (in some studies other infections different from VAP cause changes in serum biomarkers). The true diagnostic value of these substances lies in reinforcing the habitual clinical algorithm; when interpreting the results, we should take into consideration all the factors that may modify the inflammatory response.
Keywords: Biomarkers, ventilator-associated pneumonia, C-reactive protein, procalcitonin, sTREM-1, cytokines
Current Respiratory Medicine Reviews
Title: Systemic Inflammatory Response as a Risk and Prognosis Factor in Ventilator-Associated Pneumonia
Volume: 6 Issue: 1
Author(s): Paula Ramirez, Miquel Ferrer and Antoni Torres
Affiliation:
Keywords: Biomarkers, ventilator-associated pneumonia, C-reactive protein, procalcitonin, sTREM-1, cytokines
Abstract: Any important aggression toward our bodies leads to a complex systemic inflammatory response that can be expressed by biomarkers. Thus biomarkers can help us to diagnose and manage the initial aggression. Application of biomarkers to ventilator-associated pneumonia (VAP) has two additional difficulties: the lack of universal consensus regarding the diagnostic criteria and the difficulty of discriminating the inflammatory response secondary to VAP in a context (that of ventilated critical-care patients) in which there is already a nonspecific inflammatory response. However, biomarkers have been studied in VAP and promising results have been achieved concerning diagnosis and follow-up. The most studied biomarkers have been C-reactive protein, procalcitonin, sTREM-1 and cytokines. Nevertheless, heterogeneicity of results makes difficult to apply conclusions to the general ICU population. Authors differ in VAP diagnosis criteria and in the selection of the control group (in some studies other infections different from VAP cause changes in serum biomarkers). The true diagnostic value of these substances lies in reinforcing the habitual clinical algorithm; when interpreting the results, we should take into consideration all the factors that may modify the inflammatory response.
Export Options
About this article
Cite this article as:
Ramirez Paula, Ferrer Miquel and Torres Antoni, Systemic Inflammatory Response as a Risk and Prognosis Factor in Ventilator-Associated Pneumonia, Current Respiratory Medicine Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339810790820395
DOI https://dx.doi.org/10.2174/157339810790820395 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Marfan Syndrome and Related Heritable Thoracic Aortic Aneurysms and Dissections
Current Pharmaceutical Design Neuroprotective Effects of Ginkgolide B Against Ischemic Stroke: A Review of Current Literature
Current Topics in Medicinal Chemistry Heart Failure in South America
Current Cardiology Reviews Molecular Dynamics Simulations of Novel Potential Inhibitors for Penicillin Binding Protein 2B of the Resistant 5204 Strain of Streptococcus pneumoniae
Current Computer-Aided Drug Design The Management of the Infected Diabetic Foot
Current Diabetes Reviews Neuromuscular Disorders in Left Ventricular Hypertrabeculation/Noncompaction
Current Pharmaceutical Design Inside the Pan-genome - Methods and Software Overview
Current Genomics Editorial [Hot topic:Thromboembolism in Patients with Malignancy (Guest Editor: Ioannis Starakis)]
Cardiovascular & Hematological Disorders-Drug Targets Reducing the Development of Antibiotic Resistance in Critical Care Units
Current Pharmaceutical Biotechnology Prokaryotic Substrate-Binding Proteins as Targets for Antimicrobial Therapies
Current Drug Targets Editorial [Hot topic: Infective Endocarditis (Guest Editor: Ioannis Starakis)]
Infectious Disorders - Drug Targets Echocardiographic Hemodynamic Monitoring in the Critically Ill Patient
Current Cardiology Reviews Proteomic and Bioinformatics Tools to Understand Virulence Mechanisms in Staphylococcus aureus
Current Proteomics Bivalirudin: Alternative Anticoagulation During Cardiopulmonary Bypass in Patients with Heparin-Induced Thrombocytopenia
Recent Patents on Cardiovascular Drug Discovery Community-Acquired Pneumonia in Children
Recent Patents on Inflammation & Allergy Drug Discovery Liposome-Nanogel Structures for Future Pharmaceutical Applications
Current Pharmaceutical Design Multiple Roles of Biosurfactants in Biofilms
Current Pharmaceutical Design Gene Cloning and Homology Modeling of the 3-Oxoacyl-ACP Synthase from Aeromonas hydrophila for Drug Discovery
Letters in Drug Design & Discovery Older Adults Prescribed Methadone: A Review of the Literature Across the Life Span from Opiate Initiation to Methadone Maintenance Treatment
Current Drug Abuse Reviews Cardiovascular Diseases in Pregnancy - A Brief Overview
Current Cardiology Reviews